Citadel Advisors’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.2M | Buy |
1,427,201
+15,241
| +1% | +$162K | ﹤0.01% | 1121 |
|
|
2025
Q1 | $16M | Buy |
1,411,960
+72,290
| +5% | +$817K | ﹤0.01% | 1003 |
|
|
2024
Q4 | $14.1M | Buy |
1,339,670
+7,020
| +0.5% | +$73.7K | ﹤0.01% | 1124 |
|
|
2024
Q3 | $13.9M | Buy |
1,332,650
+142
| +0% | +$1.48K | ﹤0.01% | 1064 |
|
|
2024
Q2 | $13.6M | Buy |
1,332,508
+55
| +0% | +$562 | ﹤0.01% | 1063 |
|
|
2024
Q1 | $13.8M | Buy |
+1,332,453
| New | +$13.8M | ﹤0.01% | 1092 |
|